SRTS Q3'26 Earnings: EPS estimate is (0.06) USD

What happened

Sensus Healthcare, trading as SRTS, is set to announce Q3'26 results on October 29 at 8:00 AM ET. The revenue estimate is 6.61 million USD and the EPS estimate is (0.06) USD, which means an expected loss per share.

Confirmed

Global impact / market context

An expected loss of six cents per share means analysts see costs exceeding profit, so cash available matters. Revenue estimates also sit below the year-earlier reported figure, so a miss could pressure the share price and raise questions about funding operations.

Analyst inference

The estimates point to a smaller business than a year earlier, when reported revenue was higher. Prior quarters showed large swings between estimates and actual results, so the reported numbers could move the stock well beyond the headline estimates.

Analyst inference

What to watch

1. Watch whether SRTS reports revenue above or below the 6.61 million USD estimate and EPS above or below (0.06) USD when results arrive on October 29 at 8:00 AM ET. Confirmed
2. Company guidance on future sales and spending could show whether the recent revenue decline is stabilizing or continuing, which would shape expectations for coming quarters and any need to raise new money. Proposed
3. Investors should watch cash available and cost control, because continued losses at the (0.06) USD per-share estimate would raise questions about how long the company can fund operations without new financing. Analyst inference

Evidence

• Original source link unavailable